Should MSCs treat Intervertebral Disc Degeneration?
Manage episode 346462509 series 3027078
コンテンツは David Rosenblum, MD, David Rosenblum, and MD によって提供されます。エピソード、グラフィック、ポッドキャストの説明を含むすべてのポッドキャスト コンテンツは、David Rosenblum, MD, David Rosenblum, and MD またはそのポッドキャスト プラットフォーム パートナーによって直接アップロードされ、提供されます。誰かがあなたの著作物をあなたの許可なく使用していると思われる場合は、ここで概説されているプロセスに従うことができますhttps://ja.player.fm/legal。
A review of the evidence David Rosenblum, MD reviews the description and evidence provided by Loibi et al in the published article referenced below. Dr. Rosenblum discusses personal experiences with treating back pain with regenerative medicine procedures. Discussed in this podcast: Patient selection Pathophysiology Environment of the disc and it’s impact on MSCs Risks and safety concerns of Intervertebral mesenchymal stem cell transplantation Pain relief and recommendations for MSC injection into the disc in patients suffering from discogenic pain Claim CME Credit The CE experience for this Podcast is powered by CMEfy - click here to reflect and earn credits: https://earnc.me/WAltmH Course Calendar
…
continue reading
- Ultrasound Training Dominican Republic- November 12, 2022
- Physician Networking Event- November 17, 2022
- Ultrasound Training NYC- December 3, 2022
- Regenerative Interventional Pain Course January 28th, 2023
- Ultrasound Training Costa Rica- February 29, 2023
References
Loibl, M, Wuertz-Kozak, K, Vadala, G, Lang, S, Fairbank, J, Urban, JP. Controversies in regenerative medicine: Should intervertebral disc degeneration be treated with mesenchymal stem cells? JOR Spine. 2019; 2:e1043. https://doi.org/10.1002/jsp2.104399 つのエピソード